IBM的财务报表 (All
numbers in thousands)
Balance Sheet
Period Ending |
Dec 31, 2010 |
Dec 31, 2009 |
Dec 31, 2008 |
|
Assets |
Current Assets |
|
Cash And Cash
Equivalents |
10,661,000 |
12,183,000 |
12,741,000 |
|
Short Term
Investments |
990,000 |
1,791,000 |
166,000 |
|
Net
Receivables |
29,789,000 |
28,523,000 |
29,097,000 |
|
Inventory |
2,450,000 |
2,494,000 |
2,701,000 |
|
Other Current
Assets |
4,226,000 |
3,946,000 |
4,299,000 |
|
Total Current
Assets |
48,116,000 |
48,935,000 |
49,004,000 |
Long
Term Investments |
16,326,000 |
16,023,000 |
12,757,000 |
Property Plant and Equipment |
14,096,000 |
14,165,000 |
14,305,000 |
Goodwill |
25,136,000 |
20,190,000 |
18,226,000 |
Intangible Assets |
3,488,000 |
2,513,000 |
2,878,000 |
Accumulated Amortization |
-
|
-
|
-
|
Other
Assets |
3,068,000 |
3,001,000 |
3,536,000 |
Deferred Long Term Asset Charges |
3,220,000 |
4,195,000 |
8,818,000 |
|
Total Assets |
113,452,000 |
109,022,000 |
109,524,000 |
|
Liabilities |
Current Liabilities |
|
Accounts
Payable |
22,204,000 |
20,990,000 |
20,960,000 |
|
Short/Current
Long Term Debt |
6,778,000 |
4,168,000 |
11,236,000 |
|
Other Current
Liabilities |
11,580,000 |
10,845,000 |
10,239,000 |
|
Total Current
Liabilities |
40,562,000 |
36,002,000 |
42,435,000 |
Long
Term Debt |
21,846,000 |
21,932,000 |
23,391,000 |
Other
Liabilities |
24,204,000 |
24,772,000 |
26,791,000 |
Deferred Long Term Liability Charges |
3,666,000 |
3,562,000 |
3,441,000 |
Minority Interest |
126,000 |
118,000 |
-
|
Negative Goodwill |
-
|
-
|
-
|
|
Total
Liabilities |
90,405,000 |
86,385,000 |
96,058,000 |
|
Stockholders'
Equity |
Misc
Stocks Options Warrants |
-
|
-
|
-
|
Redeemable Preferred Stock |
-
|
-
|
-
|
Preferred Stock |
-
|
-
|
-
|
Common Stock |
45,418,000 |
41,810,000 |
39,129,000 |
Retained Earnings |
92,532,000 |
80,900,000 |
70,353,000 |
Treasury Stock |
(96,161,000) |
(81,243,000) |
(74,171,000) |
Capital Surplus |
-
|
-
|
-
|
Other
Stockholder Equity |
(18,743,000) |
(18,830,000) |
(21,845,000) |
|
Total Stockholder
Equity |
23,046,000 |
22,637,000 |
13,466,000 |
|
Net Tangible
Assets |
(5,578,000) |
(66,000) |
(7,638,000) |
|
|
Currency in USD.
Income
Statement
Period Ending |
Dec 31, 2010 |
Dec 31, 2009 |
Dec 31, 2008 |
Total Revenue |
99,870,000 |
95,758,000 |
103,630,000 |
Cost
of Revenue |
53,857,000 |
51,973,000 |
57,969,000 |
|
Gross Profit |
46,014,000 |
43,785,000 |
45,661,000 |
|
|
Operating Expenses |
|
Research
Development |
6,026,000 |
5,820,000 |
6,337,000 |
|
Selling General
and Administrative |
20,683,000 |
19,775,000 |
23,386,000 |
|
Non
Recurring |
-
|
-
|
(1,153,000) |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating
Expenses |
-
|
-
|
-
|
|
|
Operating Income or
Loss |
19,305,000 |
18,190,000 |
17,091,000 |
|
|
Income from Continuing Operations |
|
Total Other
Income/Expenses Net |
787,000 |
351,000 |
297,000 |
|
Earnings Before
Interest And Taxes |
20,091,000 |
18,540,000 |
17,388,000 |
|
Interest
Expense |
368,000 |
402,000 |
673,000 |
|
Income Before
Tax |
19,723,000 |
18,138,000 |
16,715,000 |
|
Income Tax
Expense |
4,890,000 |
4,713,000 |
4,381,000 |
|
Minority
Interest |
-
|
-
|
-
|
|
|
|
Net Income From
Continuing Ops |
14,833,000 |
13,425,000 |
12,334,000 |
|
|
Non-recurring Events |
|
Discontinued
Operations |
-
|
-
|
-
|
|
Extraordinary
Items |
-
|
-
|
-
|
|
Effect Of
Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
|
|
Net Income |
14,833,000 |
13,425,000 |
12,334,000 |
Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
Net Income Applicable To
Common Shares |
14,833,000 |
13,425,000 |
12,334,000 |
|
|
Currency in USD.
Cash
Flow
Period Ending |
Dec 31, 2010 |
Dec 31, 2009 |
Dec 31, 2008 |
Net Income |
14,833,000 |
13,425,000 |
12,334,000 |
|
Operating Activities, Cash
Flows Provided By or Used In |
Depreciation |
4,831,000 |
4,994,000 |
5,450,000 |
Adjustments To Net Income |
1,122,000 |
1,936,000 |
2,221,000 |
Changes In Accounts Receivables |
(489,000) |
2,131,000 |
274,000 |
Changes In Liabilities |
(1,789,000) |
(2,295,000) |
(2,633,000) |
Changes In Inventories |
92,000 |
263,000 |
(102,000) |
Changes In Other Operating Activities |
949,000 |
319,000 |
1,268,000 |
|
Total Cash Flow From Operating
Activities |
19,549,000 |
20,773,000 |
18,812,000 |
|
Investing Activities, Cash
Flows Provided By or Used In |
Capital Expenditures |
(4,185,000) |
(3,447,000) |
(4,171,000) |
Investments |
1,343,000 |
(2,189,000) |
1,494,000 |
Other
Cash flows from Investing Activities |
(5,666,000) |
(1,094,000) |
(6,608,000) |
|
Total Cash Flows From
Investing Activities |
(8,507,000) |
(6,729,000) |
(9,285,000) |
|
Financing Activities, Cash
Flows Provided By or Used In |
Dividends Paid |
(3,177,000) |
(2,860,000) |
(2,585,000) |
Sale
Purchase of Stock |
(11,601,000) |
(4,377,000) |
(6,804,000) |
Net
Borrowings |
2,350,000 |
(7,463,000) |
(2,445,000) |
Other
Cash Flows from Financing Activities |
-
|
-
|
-
|
|
Total Cash Flows From
Financing Activities |
(12,429,000) |
(14,700,000) |
(11,834,000) |
Effect Of Exchange Rate Changes |
(135,000) |
98,000 |
57,000 |
|
Change In Cash and Cash
Equivalents |
(1,522,000) |
(558,000) |
(2,250,000) |
|
|
Currency in USD.
|
|
|